Reply to the letter by Law et al. Is Rituximab therapy in Castleman's disease a risk factor for Kaposi sarcoma reactivation?
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-03-15
著者
-
Nicoli Paolo
Department Of Clinical And Biological Sciences University Of Turin San Luigi Hospital
-
GUERRASIO Angelo
Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital
-
Guerrasio Angelo
Department Of Clinical And Biological Sciences University Of Turin San Luigi Hospital